A multifaceted approach in leveraging electronic health record tools for safe inpatient use of concentrated U-500 insulin.

Purpose: The Institute for Safe Medication Practices classifies subcutaneous insulin as a high-risk medication. Concentrated U-500 insulin carries additional risks in comparison to conventional U-100 insulin, as the 5-fold more concentrated nature of this product, limitations to insulin pen dosing, and various devices for dose measurement may lead to miscommunication of patient-reported doses, resulting in downstream errors in ordering, verification, or administration. We describe a multifaceted approach to leveraging technical tools within the electronic health record (EHR) for U-500 insulin use.

Comparison of IV oncology infusions compounded via robotics and gravimetrics-assisted workflow processes.

Purpose: A study was conducted to compare an intravenous (IV) gravimetric technology-assisted workflow (TAWF) platform to an IV robotic system. In the study we reviewed both IV technology platforms using the same gravimetric quality assurance system, which allowed for direct comparison.

Methods: All oncology preparations compounded from January 2016 through December 2018 using either system were included in our retrospective analysis.